Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2015
Total Assets: $54.23B
Liabilities Breakdown FY2015
Total Liabilities: $24.31B
Asset Breakdown
Total Assets: $54.23B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.95B | 12.8% |
| Accounts Receivable | $5.35B | 9.9% |
| Inventory | $3.97B | 7.3% |
| Property, Plant & Equipment | $6.54B | 12.1% |
| Goodwill | $19.03B | 35.1% |
| Intangible Assets | $7.68B | 14.2% |
| Other Assets | $4.73B | 8.7% |
Liabilities Breakdown
Total Liabilities: $24.31B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.92B | 7.9% |
| Long-Term Debt | $8.36B | 34.4% |
| Other Liabilities | $14.03B | 57.7% |